Tags
Aktuelle Nachrichten
America
Aus Aller Welt
Breaking News
Canada
DE
Deutsch
Deutschsprechenden
Europa
Europe
Global News
Internationale Nachrichten aus aller Welt
Japan
Japan News
Kanada
Konflikt
Korea
Krieg in der Ukraine
Latest news
Map
Nachrichten
News
News Japan
Polen
Russischer Überfall auf die Ukraine seit 2022
Science
South Korea
Ukraine
UkraineWarVideoReport
Ukraine War Video Report
Ukrainian Conflict
United Kingdom
United States
United States of America
US
USA
USA Politics
Vereinigte Königreich Großbritannien und Nordirland
Vereinigtes Königreich
Welt
Welt-Nachrichten
Weltnachrichten
Wissenschaft
World
World News
1 Comment
Snippets from the article:
History will remember Biden for his aggressive actions against covid-19, most notably for his part in a mass vaccination campaign that saved an estimated 3.2 million Americans in two years. Two other areas that deserve highlighting are his efforts to curb the opioid epidemic and to make prescription drugs more affordable.
When Biden’s term started, the number of overdose deaths was skyrocketing at a relentless 31 percent a year. The administration’s bold overdose prevention efforts contributed to a remarkable reversal. The Centers for Disease Control and Prevention reports that the year ending in June saw a 14.5 percent decrease in overdose deaths. This is the single-largest recorded reduction in U.S. history. It is also the first time since 2018 that the country has seen a decline.
Biden fulfilled his campaign promise to cut prescription drug costs for seniors. His signature achievement, the Inflation Reduction Act, contained numerous provisions to make it easier for older adults to afford medications. One of them is a cap on out-of-pocket spending for those enrolled in Medicare Part D. That means no one with Part D has to pay more than $2,000 a year for prescription drugs.
In 2026, there will be additional savings because of another historic “first”: Medicare has been allowed to negotiate the prices of drugs with manufacturers. For the first 10 drugs that the administration selected to negotiate, prices for Medicare beneficiaries are 38 to 79 percent lower than list prices. Approximately 9 million people will see a direct benefit, with more to come as CMS is slated to add 15 more drugs next month.